你提供的照片可能用于改善必应图片处理服务。
隐私政策
|
使用条款
试用视觉搜索
使用图像搜索、识别对象和文本、翻译或解决问题
将一个或多个图像拖到此处,
上传图像
或
打开相机
将图像放到此处以开始搜索
要使用可视化搜索,请在浏览器中启用相机
English
全部
搜索
图片
灵感
创建
集合
视频
地图
资讯
更多
购物
航班
旅游
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
仅限颜色
黑白
类型
全部
照片
剪贴画
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
仅脸部
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
清除筛选条件
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
5124×2882
www.fiercebiotech.com
biotech layoffs | Fierce Biotech
4500×3000
www.fiercebiotech.com
Sage lays off half of R&D team and shakes up C-suite again
2138×1204
www.fiercebiotech.com
Recursion lays off 20% of staff in wake of pipeline cutbacks
2308×1298
www.fiercebiotech.com
Aldeyra’s dry eye drug suffers second FDA rejection, but imminent data ...
6000×3385
www.fiercebiotech.com
Merck & Co. pens $2B deal for Hengrui's phase 2 heart disease med
3602×2026
www.fiercebiotech.com
Enanta halts work on joint hMPV-RSV drug to extend cash to 2027
2000×1125
www.fiercebiotech.com
Asher drops 60% of staff to zero in on lead immunotherapy
4000×2250
www.fiercebiotech.com
I-Mab sheds China footprint to transform into US-based biotech
7424×4176
www.fiercebiotech.com
Avanos taps Siemens Healthineers' Americas president as CEO
5000×2812
www.fiercebiotech.com
Merck pays $700M for bispecific, spying autoimmune opening and chance ...
3640×2048
www.fiercebiotech.com
GSK posts data on HIV assets vying for roles in 6-month combo
4608×2578
www.fiercebiotech.com
AbbVie pays Gubra $350M to make late play for obesity space
2180×1224
www.fiercebiotech.com
GSK pens $2.5B pact for ABL's blood-brain barrier-bypassing tech
5904×3321
www.fiercebiotech.com
GSK axes vaccine from $2.1B deal, switches to preclinical heir
2088×1180
www.fiercebiotech.com
Bayer-owned BlueRock lays off 50 employees, shuts Cambridge labs
1732×1732
www.fiercebiotech.com
Biogen CMO heads for the exits
2235×1263
www.fiercebiotech.com
Illumina picks up proteomics developer SomaLogic from Standard BioTools ...
2120×1187
www.fiercebiotech.com
AstraZeneca details $2.5B investment in China's political center
7111×4000
www.fiercebiotech.com
Juri inks $210M T-cell engager deal with China biotech
3181×2122
www.fiercebiotech.com
Edwards excites with Evoque FDA approval in transcatheter tricusp…
3840×2160
www.fiercebiotech.com
ITM shares details of radiotherapy's phase 3 win, reveals OS miss
2000×1129
www.fiercebiotech.com
Abcuro takes $200M series C to fund KLRG1 antibody pivotal trial
1920×1080
www.fiercebiotech.com
CytomX lays off 40%, mulls future of Amgen-partnered drug
5374×3023
www.fiercebiotech.com
Zealand's dual agonist tied to 11% weight loss in phase 1b
2500×1407
www.fiercebiotech.com
Zenas, Bicara set out to raise $180M-plus in separate IPOs
6586×3796
www.fiercebiotech.com
Biogen pays Stoke $165M, bagging Dravet drug to fire up pipeline
5000×2813
www.fiercebiotech.com
SpectraWAVE collects $50M for coronary imaging catheters and AI
1956×1103
www.fiercebiotech.com
Investor pressures Essa to liquidate, give cash to shareholders
2000×1500
www.fiercebiotech.com
Novartis pays $150M for Arvinas' prostate tumor prote…
3226×1815
www.fiercebiotech.com
Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout
2121×1191
www.fiercebiotech.com
‘Too big and unfocused’: Trump slashes NIH budget by $18B
2213×1245
www.fiercebiotech.com
The JPM pregame: Jam-packed Jefferies conference makes its mark
2309×1299
www.fiercebiotech.com
Lundbeck signs $2.5B check for Longboard and its epilepsy med
2121×1414
www.fiercebiotech.com
Biogen, UCB report phase 3 lupus win after failing earlier trial
2121×1414
www.fiercebiotech.com
Eli Lilly to pay Mediar $99M for pulmonary fibrosis prospect
某些结果已被隐藏,因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈